Susquehanna International Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
139,782
+85,503
| +158% | +$2.37M | ﹤0.01% | 1561 |
|
|
2025
Q1 | $1.21M | Sell |
54,279
-23,829
| -31% | -$529K | ﹤0.01% | 3042 |
|
|
2024
Q4 | $1.54M | Buy |
78,108
+11,541
| +17% | +$228K | ﹤0.01% | 2331 |
|
|
2024
Q3 | $1.66M | Buy |
66,567
+55,957
| +527% | +$1.4M | ﹤0.01% | 2063 |
|
|
2024
Q2 | $198K | Sell |
10,610
-120,613
| -92% | -$2.25M | ﹤0.01% | 4749 |
|
|
2024
Q1 | $2.59M | Buy |
131,223
+95,330
| +266% | +$1.88M | ﹤0.01% | 1541 |
|
|
2023
Q4 | $630K | Sell |
35,893
-173,527
| -83% | -$3.04M | ﹤0.01% | 3530 |
|
|
2023
Q3 | $3.64M | Buy |
209,420
+195,772
| +1,434% | +$3.4M | ﹤0.01% | 1332 |
|
|
2023
Q2 | $192K | Sell |
13,648
-83,430
| -86% | -$1.17M | ﹤0.01% | 4669 |
|
|
2023
Q1 | $1.04M | Buy |
97,078
+52,776
| +119% | +$568K | ﹤0.01% | 2832 |
|
|
2022
Q4 | $664K | Buy |
+44,302
| New | +$664K | ﹤0.01% | 2833 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6545 |
|
|
2022
Q2 | – | Sell |
-30,868
| Closed | -$307K | – | 6274 |
|
|
2022
Q1 | $307K | Sell |
30,868
-86,673
| -74% | -$862K | ﹤0.01% | 4324 |
|
|
2021
Q4 | $1.38M | Sell |
117,541
-9,650
| -8% | -$114K | ﹤0.01% | 2420 |
|
|
2021
Q3 | $1.45M | Buy |
127,191
+32,178
| +34% | +$367K | ﹤0.01% | 2307 |
|
|
2021
Q2 | $1.32M | Buy |
95,013
+34,140
| +56% | +$476K | ﹤0.01% | 2605 |
|
|
2021
Q1 | $1.13M | Buy |
60,873
+49,112
| +418% | +$909K | ﹤0.01% | 2840 |
|
|
2020
Q4 | $208K | Sell |
11,761
-4,524
| -28% | -$80K | ﹤0.01% | 4236 |
|
|
2020
Q3 | $249K | Buy |
+16,285
| New | +$249K | ﹤0.01% | 3720 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4589 |
|